Generic Novolin 70/30
At this point, it is impossible to predict when (or even if) any generic Novolin 70/30 products may become available. Novolin 70/30 is a "biologic" drug that is regulated by different laws and rules than most other medications. Currently, generic biologics are not allowed to be manufactured in the United States.
Novolin® 70/30 (NPH insulin/regular insulin) is a diabetes medication that is available without a prescription. It contains a combination of 70 percent NPH insulin (an intermediate-acting insulin) and 30 percent regular insulin (a short-acting insulin). It is typically taken twice a day before meals.
Novolin 70/30 is made by Novo Nordisk. At this time, there are no generic versions of Novolin 70/30 or any other insulin medications. Other insulin mixtures are available, but none of them are equivalent to Novolin 70/30, and, more importantly, none of them are generic medications.
Like all insulins, Novolin 70/30 is considered a "biologic" medication. As a result, it is regulated by different rules and laws than most other medications. At this point, generic biologics, including generic Novolin 70/30, are not allowed to be manufactured in the United States. Currently, legislation is under way that may change the laws concerning generic biologics, but it is not clear when (or even if) this may happen.
At this point, it is impossible to predict when or if a generic version of Novolin 70/30 may become available.
There is no reason why anyone should go without insulin simply because they cannot afford it. Several different programs are available (some charitable, some government-funded) that help people with diabetes afford their medications. If you cannot afford Novolin 70/30, ask your healthcare provider or pharmacist about such programs.